Foundation for Innovative New Diagnostics

Foundation for Innovative New Diagnostics is an organisation in Geneve, Switzerland that has taken part in 11 EU-funded projects since 2008, receiving €2.7M in EU funding.

EU funding received€2.7M
EU projects11
As coordinator0
Running now4
First EU project2008
Latest project2025
CountrySwitzerland
EU registration (PIC)999679964
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Foundation for Innovative New Diagnostics's own share of each project, not the project's full budget.

  • Horizon 2020€1.4M · 5 projects
  • FP7 (2007 to 2013)€894k · 3 projects
  • Horizon Europe€410k · 3 projects

Projects

11 EU-funded projects, newest first. Each links to the official record.

  • CAD LUS4TBAssociated partner

    Computer assisted diagnosis with lung ultrasound for community based pulmonary tuberculosis triage in Benin, Mali and South-Africa

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • PvSeroRDTAssociated partner

    A point-of-care serological rapid diagnostic test for risk of Plasmodium vivax hypnozoite infection (PvSeroRDT)

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • PvSTATEMPartner

    SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €410ktheir share
  • UNITE4TBPartner

    ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS

    Horizon 2020 · 2021–2028 · Project on CORDIS ↗

    €1.0Mtheir share
  • VALUE-DxPartner

    The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €75ktheir share
  • A-PatchPartner

    Autonomous Patch for Real-Time Detection of Infectious Disease

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

    €257ktheir share
  • MofinaPartner

    Mobile Filovirus Nucleic Acid Test – Sofia ref.: 115848

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

  • EUROLEISH-NETPartner

    Control of leishmaniasis, from bench to bedside and community

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • NANOTRYPPartner

    Exploiting Nanobodies in development of new diagnostic tools and treatment methods for Trypanosomiasis

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €283ktheir share
  • TB PAN-NETPartner

    Pan-European network for the study and clinical management of drug resistant tuberculosis

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €311ktheir share
  • TM-RESTPartner

    A new platform for fast molecular detection of MDR and XDR resistant strains of M. tuberculosis and of drug resistant malaria

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €300ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • antibiotic resistance
  • drug resistance
  • ebola
  • epidemiology
  • infectious diseases
  • malaria
  • microbiology
  • molecular biology
  • multidrug resistance
  • nongovernmental organizations
  • nucleic acids
  • parasitology
  • proteins

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime